By Staff
Friday, August 12, 2022 12:21 AM
LAKE FOREST, Calif.—
STAAR Surgical (NASDAQ: STAA), based here, reported record net sales and a record number of ICL (Implantable Collamer Lens) units sold during the second quarter which ended July 1, 2022. The company posted 2Q net sales of $81.1 million, up 30 percent compared to $62.4 million reported in the prior year quarter. STAAR Surgical attributed the sales increase to ICL sales and unit growth of 32 percent and 42 percent, respectively, as compared to the prior year period.
By Staff
Friday, August 12, 2022 12:18 AM
BOSTON—
FundamentalVR reported that it has raised an additional $20 million to significantly accelerate medical skill-transfer and increase surgical proficiency through its medical simulation platform,
Fundamental Surgery. The transaction was led by
EQT Life Sciences investing from the LSP Health Economics Fund 2 and joined by prior investors
Downing Ventures. The new investments follow a Series A round in October 2019 and brings the company’s total funding to over $30 million. FundamentalVR is a scalable medical simulation platform combining virtual reality and haptics through data, artificial intelligence, and multimodal learning.
By Staff
Wednesday, August 10, 2022 12:18 AM
ADELAIDE, Australia—
Nova Eye Medical Limited, an ophthalmic technology company based here, is launching the iTrack Global Data Registry to collect prospective, multicenter, longitudinal data for canaloplasty in the treatment of glaucoma.
By Staff
Wednesday, August 10, 2022 12:15 AM
ORLANDO, Fla.—
LensAR, Inc., a medical technology company focused on femtosecond laser treatment of cataracts, generated $8.0 million in revenue for the quarter ended June 30, 2022, an increase of $0.1 million, or 1 percent.
By Staff
Monday, August 8, 2022 12:30 AM
JENA, Germany—
Carl Zeiss Meditec (ISIN: DE 0005313704) generated revenue of €1,332.9 million in the first nine months of fiscal year 2021/22 (prior year: €1,198.2 million), corresponding to an increase of 11.2 percent (adjusted for currency effects: +9.8 percent) compared with the same period of the prior year. Order intake increased at a much higher rate than revenue, rising 36.0 percent to €1,750.5 million (prior year: €1,287.6 million). Earnings before interest and taxes (EBIT) at €275.9 million were only slightly below the previous year's level of €282.8 million, which had still benefited considerably from lower operating costs during the COVID-19 pandemic.
By Staff
Monday, August 8, 2022 12:15 AM
SUWON, South Korea—
OliX Pharmaceuticals (KOSDAQ: 226950), a developer of RNAi therapeutics, announced that the
U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to develop OLX10212 for the treatment of age-related macular degeneration (AMD).
By Staff
Friday, August 5, 2022 12:18 AM
ALISO VIEJO, Calif.—
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company, reported net sales of $72.7 million in the second quarter of 2022 ended June 30, 2022, a 6.9 percent drop compared with the same period in 2021. Gross margin for the second quarter of 2022 was approximately 75 percent, compared to approximately 77 percent in the same period in 2021. Non-GAAP gross margin for the second quarter of 2022 was approximately 83 percent, compared to approximately 84 percent in the same period in 2021.
By Staff
Thursday, August 4, 2022 12:18 AM
MIAMI—
Bascom Palmer Eye Institute of the University of Miami Health System has been ranked again as the nation’s best in ophthalmology by
U.S. News & World Report. This year marks the 21st time that Bascom Palmer has received the number one ranking since the publication began surveying U.S. physicians for its annual “Best Hospitals” rankings 33 years ago. “Our professional team is dedicated to delivering the best possible vision care to patients throughout our diverse community and around the world,” said Eduardo C. Alfonso, MD, director of Bascom Palmer Eye Institute, and the Kathleen and Stanley J. Glaser chair in ophthalmology.
By Staff
Tuesday, August 2, 2022 12:21 AM
SEATTLE—
LumiThera Inc., a medical device company offering photobiomodulation treatment for ocular damage and disease, announced the purchase of
MacuLogix assets by its wholly owned subsidiary.
By Staff
Monday, August 1, 2022 12:18 AM
ST. LOUIS—The
World Council of Optometry (WCO) and
Alcon have partnered to form a global, evidence-based dry eye disease education initiative designed to raise optometrists’ understanding of dry eye etiology and prevalence, diagnosis, and practical management. WCO president Peter Hendicott MAppSc, PhD said, “We are excited to partner with Alcon in supporting the education of optometrists globally about practical measures to better address dry eye, a condition that without proper diagnosis and treatment can lead to ocular surface disease. July is Dry Eye Awareness Month—the ideal launching point for this year-long program. By raising the conversation around dry eye, the eyecare community can collectively improve outcomes from a condition that can significantly affect people’s vision and lives.”
By Staff
Monday, August 1, 2022 12:15 AM
NEW YORK—To further its goal of educating independent, private eyecare practice owners and managers,
Independent Strong has named Jennifer L. Stewart, OD, as its professional editor. With experience in academia and in private practice, Dr. Stewart has been a proponent of private independent practice optometry and opticianry her entire career. She will be responsible for directing the vision and mission of the overall website, planning the content written for each issue by practicing eye care professionals in the field, and working alongside the in-house editorial team of editor-in-chief John Sailer and managing editor Kristen Dalli.
By Staff
Friday, July 29, 2022 12:18 AM
CORALVILLE, Iowa—
Digital Diagnostics announced that it is partnering with
ArchWell Health to bring IDx-DR, its proprietary autonomous AI diagnostic system, to ArchWell Health centers across the U.S, according to an announcement. IDx-DR is designed to detect diabetic retinopathy and diabetic macular edema at the point-of-care. Earlier this year Digital Diagnostics, based here, changed its name from IDx, as
VMAIL reported. ArchWell Health, based in Nashville, Tenn., is a health care company serving seniors.
By Staff
Thursday, July 28, 2022 12:21 AM
CHICAGO—August is Children’s Eye Health and Safety Month, and 2022 is the “Year of Children’s Vision” at the national non-profit,
Prevent Blindness. The nation’s leading volunteer eye health and safety organization is offering a wide variety of free resources.